Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines

Artikel in diesem Heft

1. Guest Editorial
2. Novel paradigms in vaccine development: from small pox eradication to therapeutic vaccines
3. Highlight: 3rd Semmering Conference 2007
4. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine
5. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors
6. Novel strategies to identify biomarkers in tuberculosis
7. Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection
8. Lipopolysaccharide: a tool and target in enterobacterial vaccine development
9. The coming of age of virus-like particle vaccines
10. Maintenance of serological memory
11. Adjuvant activity of type I interferons
12. Japanese encephalitis vaccines – needs, flaws and achievements
13. Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals
14. Non-regulatory CD8⁺CD45RO⁺CD25⁺ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8⁺CD45RA⁺ T-cells in old age
15. Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
16. Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties
17. Review
18. RNA switches regulate initiation of translation in bacteria
19. Protein Structure and Function
20. Inhibition of bacterial oxidases by formamide and analogs
21. Modeling of variant copies of subunit D1 in the structure of photosystem II from Thermosynechococcus elongatus